- Medicamen Biotech
Medicamen Biotech
NSE: MEDICAMEQ | BSE: 531146
₹449.50
+₹17.00 (3.93%) TodayLast updated on 05 May, 2025 | 15:29 ISTMarket cap  ₹587 Crs | Open ₹435.00 | Prev. Close ₹432.50 |
Circuit range ₹519.00 - ₹346.00 | Day range ₹426.50 - ₹449.90 | Year range ₹375.05 - ₹630.00 |
Volume 14,487 | Avg. traded ₹437.27 | Revenue (12m) ₹180 Crs |
About Medicamen Biotech
Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.
Medicamen Biotech Share Price Chart
Please wait...
Medicamen Biotech Fundamentals
Medicamen Biotech Key indicators
52 week high ₹630.00 | 52 week low ₹375.05 | P/E ratio 55.48 |
P/B ratio 2.66 | ROE 6.85% | ROCE 10.13% |
Dividend yield 0.23% | Debt/Equity ratio 0.15 | EPS 10.46 |
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Medicamen Biotech Financial Ratios
Operating profit margin17.14% | Net profit margin7.71% |
ROE6.85% | ROA4.69% |
ROCE10.13% |
Quick ratio1.25 | Current ratio1.85 |
Interest coverage3.99 | Asset turnover0.61 |
Debt to Equity0.15 |
P/E ratio55.48 | P/B ratio2.66 |
EV / EBITDA17 | |
Dividend yield0.23% |
Revenue statement
All values are in ₹ Crores (Cr)
Loading chart data
Cash flow
All values are in ₹ Crores (Cr)
Loading chart data
Balance sheet
All values are in ₹ Crores (Cr)
No data available at the moment
Total assets
Total liabilities
Medicamen Biotech Share Price history
| Day | Open | Close | Change % |
|---|---|---|---|
Fri, May 2 2025 | ₹425.45 | ₹432.50 | |
Wed, Apr 30 2025 | ₹440.05 | ₹426.85 | -2.73% |
Tue, Apr 29 2025 | ₹444.30 | ₹438.85 | -0.74% |
Mon, Apr 28 2025 | ₹441.00 | ₹442.10 | -0.91% |
Fri, Apr 25 2025 | ₹461.40 | ₹446.15 | -2.33% |
Thu, Apr 24 2025 | ₹458.45 | ₹456.80 | -0.36% |
Wed, Apr 23 2025 | ₹473.25 | ₹458.45 | -2.34% |
Tue, Apr 22 2025 | ₹470.25 | ₹469.45 | -1.67% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 19 Sep 2024
Dividend • ₹1/share
Ex date 20 Sep 2023
More
Stocks Similar to Medicamen Biotech
Popular Stocks
Medicamen Biotech News
FAQs on Medicamen Biotech
What is the Medicamen Biotech share price today?
Medicamen Biotech share price is ₹ 449.50 as on 05 May, 2025 | 19:54 IST
What is today’s high & low share price of Medicamen Biotech?
Medicamen Biotech share price high: ₹ 449.90 and low: ₹ 426.50 as on 05 May, 2025 | 19:54 IST
What is the Medicamen Biotech share price high and low in the last 52 weeks on the NSE?
52 Week share High Price is ₹ 630.00 and Low Price is ₹ 375.05 as on 05 May, 2025 | 19:54 IST
What is the Medicamen Biotech Stock Symbol?
The Medicamen Biotech Stock symbol is MEDICAMEQ.
Can I buy Medicamen Biotech shares on Holidays?
No, shares of Medicamen Biotech or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Medicamen Biotech shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.